ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Jupiter Neurosciences Inc

Jupiter Neurosciences Inc (JUNS)

1.29
-0.12
( -8.51% )
Updated: 02:23:54

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.29
Bid
1.28
Offer
1.32
Volume
515,779
1.21 Day's Range 1.34
1.21 52 Week Range 19.51
Market Cap
Previous Close
1.41
Open
1.28
Last Trade
1
@
1.3
Last Trade Time
02:24:06
Financial Volume
US$ 666,316
VWAP
1.2919
Average Volume (3m)
758,140
Shares Outstanding
33,103,860
Dividend Yield
-
PE Ratio
-9.07
Earnings Per Share (EPS)
-0.14
Revenue
-
Net Profit
-4.78M

About Jupiter Neurosciences Inc

Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we pri... Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL¿ is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Jupiter Neurosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker JUNS. The last closing price for Jupiter Neurosciences was US$1.41. Over the last year, Jupiter Neurosciences shares have traded in a share price range of US$ 1.21 to US$ 19.51.

Jupiter Neurosciences currently has 33,103,860 shares in issue. The market capitalisation of Jupiter Neurosciences is US$46.68 million. Jupiter Neurosciences has a price to earnings ratio (PE ratio) of -9.07.

JUNS Latest News

Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials

Jupiter, Florida, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a...

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.16-71.01123595514.455.61.2133403452.99398589CS
4-9.51-88.055555555610.811.43171.2110959944.99219512CS
12-2.71-67.75419.511.217581406.65531444CS
26-2.71-67.75419.511.217581406.65531444CS
52-2.71-67.75419.511.217581406.65531444CS
156-2.71-67.75419.511.217581406.65531444CS
260-2.71-67.75419.511.217581406.65531444CS

JUNS - Frequently Asked Questions (FAQ)

What is the current Jupiter Neurosciences share price?
The current share price of Jupiter Neurosciences is US$ 1.29
How many Jupiter Neurosciences shares are in issue?
Jupiter Neurosciences has 33,103,860 shares in issue
What is the market cap of Jupiter Neurosciences?
The market capitalisation of Jupiter Neurosciences is USD 46.68M
What is the 1 year trading range for Jupiter Neurosciences share price?
Jupiter Neurosciences has traded in the range of US$ 1.21 to US$ 19.51 during the past year
What is the PE ratio of Jupiter Neurosciences?
The price to earnings ratio of Jupiter Neurosciences is -9.07
What is the reporting currency for Jupiter Neurosciences?
Jupiter Neurosciences reports financial results in USD
What is the latest annual profit for Jupiter Neurosciences?
The latest annual profit of Jupiter Neurosciences is USD -4.78M
What is the registered address of Jupiter Neurosciences?
The registered address for Jupiter Neurosciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Jupiter Neurosciences website address?
The website address for Jupiter Neurosciences is www.jupiterneurosciences.com
Which industry sector does Jupiter Neurosciences operate in?
Jupiter Neurosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GITSGlobal Interactive Technologies Inc
US$ 1.93
(1,883.56%)
14.35k
JGAurora Mobile Ltd
US$ 15.70
(161.14%)
20.02M
YIBOPlanet Image International Ltd
US$ 5.47
(154.42%)
345.51k
TOIIWOncology Institute Inc
US$ 0.0487
(118.39%)
157.65k
AKROAkero Therapeutics Inc
US$ 54.70
(108.94%)
8.29M
ALLKAllakos Inc
US$ 0.2733
(-77.41%)
16.96M
VERUVeru Inc
US$ 0.6878
(-43.16%)
20.98M
NXUNXU Inc
US$ 0.3628
(-41.10%)
2.7M
ELABPMGC Holdings Inc
US$ 2.03
(-34.52%)
2.42M
NBISNebius Group NV
US$ 29.35
(-29.60%)
13.44M
NVDANVIDIA Corporation
US$ 124.5721
(-12.65%)
190.43M
ONCOOnconetix Inc
US$ 0.83385
(73.72%)
142.31M
HOLOMicroCloud Hologram Inc
US$ 1.945
(25.48%)
134.43M
HWHHWH International Inc
US$ 0.4948
(71.98%)
83.22M
MLGOMicroAlgo Inc
US$ 2.005
(31.91%)
55.11M

JUNS Discussion

View Posts
tw0122 tw0122 2 months ago
Back down to $11 halt 38% 
👍️0
Invest-in-America Invest-in-America 2 months ago
JUNS: WHERE do you see that 120%??? Is that your price TARGET??? (Etrade, etc.,.shows only 38%.)
👍️0
tw0122 tw0122 2 months ago
$17 +120%
👍️0
Invest-in-America Invest-in-America 2 months ago
JUNS: O.K., sounds fine to me, Homeboy!!
👍️0
tw0122 tw0122 2 months ago
From Saturn off to Jupiter $11.79 + 50%
👍️0
Invest-in-America Invest-in-America 2 years ago
JUNS (IPO):
👍️0
makinezmoney makinezmoney 2 years ago
$JUNS: IPO is launching next week

We are waiting on it.



Jupiter Neurosciences, Inc. has developed the first and only resveratrol product that safely reaches therapeutic levels without GI-side effects creating treatment possibilities in many indications.

https://jupiterneurosciences.com/








GO $JUNS
👍️0
Invest-in-America Invest-in-America 2 years ago
JUNS: Evidently, now ready-to-go on E-Turd, Fidelity, etc.
👍️0
spindog spindog 3 years ago
Ticker hasn’t shown up on E*TRADE yet
👍️0
crudeoil24 crudeoil24 3 years ago
IPO scheduled for February 3, 2022.
👍️0
crudeoil24 crudeoil24 3 years ago
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer’s disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.
👍️0

Your Recent History

Delayed Upgrade Clock